News & Events about Pulse Biosciences Inc.
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary nanosecond pulsed field ablation (nsPFA) technology for electrophysiology and the treatment of atrial fibrillation, today announced its technology will be highlighted in a poster presentation at the 28th Annual...
NEW YORK, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Natera, Inc. (NASDAQ: NTRA) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Natera alleging that Defendants misrepresented and/or failed to disclose that: (i) the Companys Panorama Non-Invasive Prenatal Test...
Thinking about buying stock in Oblong, Pulse Biosciences, Inmode, Richardson Electronics, or Delta Air Lines? Thinking about buying stock in Oblong, Pulse Biosciences, Inmode, Richardson Electronics, or Delta Air Lines? PR Newswire NEW YORK, Oct. 13, 2022 NEW YORK, Oct. 13, 2022 /PRNewswire...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company developing the CellFX System powered by Nano-Pulse Stimulation (NPS) technology, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its CellFX System, expanding the indication for use...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX System powered by Nano-Pulse Stimulation (NPS) technology, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of expanded energy settings for use with the family...